Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
1.2%
Debt
0%
Liquidity
7.1%
Revenue
Debt
Liquidity
1.2%
INR Crores
| Pharmaceutical Products | ₹5.77 |
| Product development | ₹0.01 |
| Other Operating Revenue | ₹0.05 |
| Other Income | ₹0.00 |
INR Crores
| Net Gain on Sale of Investments | ₹0.06 |
INR Crores
| Interest income | ₹0.01 |
INR Crores
| Revenue from Questionable Sources: | ₹0.06 |
| Revenue from Non Compliant Sources: | ₹0.01 |
| Total: | ₹0.07 |
| Total Revenue: | ₹5.89 |
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
₹0.07
₹5.89
= 1.2%
compliant
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
